果冻影院

XClose

Joint Research Office

Home
Menu

果冻影院H research database gives 鈥榦ne click鈥 access to all clinical trials

14 May 2019

果冻影院H clinicians can now see, with just one click, all recruiting trials that their patients may be eligible for

聽uses the Keytrials platform developed by Dr Wai Keong Wong, 果冻影院H鈥檚 Chief Research Information Officer, working within the 果冻影院H Clinical Research Informatics Unit (CRIU), to improve awareness of research and improve recruitment. The public can also access the platform.

The database 鈥 which supersedes the old 果冻影院H Research Gateway 鈥 will link with 果冻影院H鈥檚 electronic health record system, known as Epic, which was rolled out in March 2019 and is now used to manage patient care, with patients having access to their own record.

鈥淥nce in the Find a Study platform, clinicians and patients are just one mouse-click or screen tap away from seeing all studies at 果冻影院H, or all studies filtered by disease area,鈥 said Dr Wong.

鈥淭he integration with Epic is a key aspect of the database. Because clinicians and patients now use Epic on a routine basis, they are much more likely to access Find a Study compared with the old system, which will help drive recruitment to research studies, and increase awareness of the breadth of research we do at 果冻影院H.鈥

key_trials

The platform will alert clinicians and patients to trials the patient may be eligible for, based on previous searches they performed.

In future, developers hope to develop an 鈥榓uto-matching鈥 system, where the platform will automatically suggest which trials a patient is suitable for, based on information in the patient鈥檚 electronic health record and eligibility criteria of studies.

While now publicly accessible, Find a Study will remain in development for the coming months, as developers use feedback from clinicians and patients to optimise the platform and improve user experience. A mobile app is also planned.

Keytrials technology was previously used in relation to blood cancer trials. Following a successful pilot, the platform was used to implement 鈥楩ind a Study鈥 that covers all trials following a BRC grant in 2018.

View the聽.